Lattanzi, Simona http://orcid.org/0000-0001-8748-0083
Brigo, Francesco
Trinka, Eugen
Vernieri, Fabrizio
Corradetti, Tommaso
Dobran, Mauro
Silvestrini, Mauro
Article History
First Online: 22 February 2019
Compliance with Ethical Standards
:
: No funding was received for the conduct of this study.
: Simona Lattanzi, Fabrizio Vernieri, Tommaso Corradetti, Mauro Dobran, and Mauro Silvestrini have no conflicts of interest directly relevant to the content of this study. Francesco Brigo has acted as a consultant for Eisai. Eugen Trinka has received speaker’s honoraria from UCB, Biogen, Gerot-Lannach, Bial, Eisai, Takeda, Newbridge, Sunovion Pharmaceuticals Inc., LivaNova and Novartis; consultancy funds from UCB, Biogen, Gerot-Lannach, Bial, Eisai, Takeda, Newbridge, GW Pharmaceuticals, Sunovion Pharmaceuticals Inc., and Novartis; directorship funds from Neuroconsult GmbH. E. Trinka’s Institution received grants from Biogen, Red Bull, Merck, UCB, European Union, FWF Österreichischer Fond zur Wissenschaftsförderung, and Bundesministerium für Wissenschaft und Forschung.